VEMO Corp. has unveiled it will be showcasing its natural alternative to growth-promoting antibiotics VemoZyme® Alternase+ at the 2025 International Production & Processing Expo (IPPE) in Atlanta, USA. Attendees can find VEMO at Booth A1003 on 28-30 January.
One of the leading manufacturers of phytogenic and enzyme-based feed additives, VEMO Corp. has announced that its solution, VemoZyme® Alternase+ will be on display at the 2025 International Production & Processing Expo (IPPE) from 28-30 January in Atlanta, USA (Booth A1003). The company points out that the solution offers farmers an effective, sustainable alternative to growth-promoting antibiotics while addressing the critical issue of antibiotic resistance.
The global agricultural industry faces a mounting challenge: the rise of antibiotic-resistant bacteria fueled by the overuse of antibiotics in livestock farming. In response, VEMO Corp. introduces VemoZyme® Alternase+, a natural alternative to growth-promoting antibiotics (GPA) that offers unparalleled antibacterial effectiveness while addressing sustainability concerns, according to the company’s announcement.
NATURAL, POWERFUL
The company explains that this enzyme-based feed additive targets harmful pathogens like Clostridium, Staphylococcus, and Streptococcus in the GI tract, enhancing livestock health without the risk of promoting bacterial resistance.
Antibiotic resistance is a global concern, and the livestock sector has a key role to play in addressing it. VEMO states that With VemoZyme® Alternase+, farmers can maintain high levels of productivity while aligning with consumer demands for antibiotic-free, naturally raised meat and legal restrictions.
The benefits of VemoZyme® Alternase+ have been explained as:
• No Resistance Risk: Unlike traditional antibiotics, it does not contribute to the development of resistant bacteria.
• Gut Health & Productivity: Enhances digestion, nutrient uptake, and immune function, leading to healthier, faster-growing animals.
• Sustainability: Reduces the environmental footprint associated with antibiotic overuse.
• Heat Stability: Maintains efficacy even at high feed-processing temperatures (up to 90°C).
PERFORMANCE IN ACTION
Extensive trials have reportedly demonstrated the following results:
• Broilers: A 7.8% improvement in the production efficiency factor (PEF), 3.1% higher live weight, and a 1.9% reduction in feed consumption per kilogram of live weight.
• Pigs: Improved gastrointestinal health, reduced pathogen shedding, and significant growth rate and feed efficiency gains.
DRIVING A SUSTAINABLE FUTURE IN AGRICULTURE
VemoZyme® Alternase+ offers a compelling solution for livestock farmers facing growing regulatory pressures and market demands for sustainable practices, VEMO states. By replacing growth-promoting antibiotics, this innovation helps:
• Preserve the efficacy of critical antibiotics for human medicine.
• Comply with stricter regulations on antibiotic use in animal farming.
• Meet consumer preferences for natural, antibiotic-free products.
Attendees can join VEMO at IPPE 2025 Atlanta, Booth A1003, to discover how VemoZyme® Alternase+ aim to shape the future of sustainable livestock farming. The company’s experts will be available to discuss the science, benefits, and applications of this solution.
